Close

Jazz Pharmaceuticals (JAZZ) PT Lowered to $190 at B.Riley/FBR

November 8, 2018 4:17 AM EST
Get Alerts JAZZ Hot Sheet
Price: $120.42 -0.07%

Rating Summary:
    31 Buy, 6 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE

B.Riley/FBR analyst David Buck lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $190.00 (from $219.00) while maintaining a Buy rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

David Buck